• DOI:10.1016/S0140-6736(19)32556-5
• Corpus ID: 208049235

Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

@article{Attal2019IsatuximabPP,
  title={Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study},
  author={Michel Attal and Paul G. Richardson and S. Vincent Rajkumar and Jesus F F San-Miguel and Meral Beksaç and Ivan {\vS}pi{\vc}ka and Xavier Leleu and F. Schjesvold and Philippe Moreau and Meletios- Athanasios Dimopoulos and Jeffrey Shang-Yi Huang and Jiř{\'i} Minař{\'i}k and Michele Cavo and Henry Miles Prince and Sandrine Mac{\'e} and Kathryn Penkus Corzo and Frank Campana and Solenn Le-Guennec and Franck Dubin and Kenneth C. Anderson and Paul G. Richardson and Vincent S. Rajkumar and Meletios- Athanasios Dimopoulos and Henry Miles Prince and Kathryn Penkus Corzo and Kenneth C. Anderson and Simon James Harrison and Wojt Janowski and Ian Kerridge and Andrew Spencer and Michel Delforge and Karel Fostier and Philip Vlummens and Ka Lung Wu and Richard LeBlanc and Michel Pavic and Michael Sebag and Roman H{\'a}jek and Vladim{\'i}r Maisnar and Ludek Pour and Henrik Gregersen and Lotfi B Benbouker and Denis Caillot and M Escoffre-barbe and Thierry Facon and Laurent Frenzel and Cyrille Hulin and Lionel Karlin and Brigitte Kolb and Brigitte P{\'e}gouri{\'e} and Aurore Perrot and Mourad Tiab and Laure Vincent and Dietger Niederwieser and Achilles Anagnostopoulos and Sosana Delimpasi and Marie-Christine Kyrtsonis and Anargyros Symeonidis and {\'A}rp{\'a}d Ill{\'e}s and G{\'a}bor Mikala and Zsolt Nagy and Sara Bringen and Paolo Corradini and Ciceri Fabio and Roberto M Lemoli and Anna Marina Liberati and Chiara Nozzoli and Renato Zambello and Shinsuke Iida and Takashi Ikeda and Satoshi Iyama and Morio Matsumoto and Chihiro Shimazaki and Kazutaka Sunami and Kenshi Suzuki and Michihiro Uchiyama and Youngil Koh and Kihyun Kim and Jae Hoon Lee and Chang-Ki Min and Hillary Blacklock and Hugh J. B. Goodman and Annette J. Neylon and David Simpson and Sebastian Grosicki and Artur Jurczyszyn and Adam Walter‐Croneck and Krzysztof Warzocha and Lu{\'i}s Ara{\'u}jo and Cl{\'a}udia Moreira and Vadim A Doronin and Larisa P. Mendeleeva and Vladimir Vorobyev and Andrej Vranovsk{\'y} and Adri{\'a}n Alegre and Mercedes Gironella and Marta Sonia Gonz{\'a}lez P{\'e}rez and Carmen Montes and Enrique Mar{\'i}a Ocio and Paula Rodriguez and Mats Hardling and Birgitta Lauri and Ming-chung Wang and Su-Peng Yeh and Mutlu Arat and Fatih Demirkan and Zafer Gulbaş and Sevgi Beşışık and Ihsan Karadoğan and Tulin Firatli Tuglular and Ali Unal and Filiz Vural and Jonathan Sive and Matthew Streetly and Kwee L. Yong and Jason Tache},
  journal={The Lancet},
  year={2019},
  volume={394},
  pages={2096-2107}
}

• M. Attal, P. Richardson, +113 authors J. Tache
• Published 14 November 2019
• Medicine
• The Lancet